Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial


Journal article


E. Grodin, S. Bujarski, Brandon Towns, E. Burnette, Steven J. Nieto, Aaron C Lim, Johnny Lin, K. Miotto, A. Gillis, M. Irwin, C. Evans, L. Ray
Translational Psychiatry, 2021

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Grodin, E., Bujarski, S., Towns, B., Burnette, E., Nieto, S. J., Lim, A. C., … Ray, L. (2021). Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Translational Psychiatry.


Chicago/Turabian   Click to copy
Grodin, E., S. Bujarski, Brandon Towns, E. Burnette, Steven J. Nieto, Aaron C Lim, Johnny Lin, et al. “Ibudilast, a Neuroimmune Modulator, Reduces Heavy Drinking and Alcohol Cue-Elicited Neural Activation: a Randomized Trial.” Translational Psychiatry (2021).


MLA   Click to copy
Grodin, E., et al. “Ibudilast, a Neuroimmune Modulator, Reduces Heavy Drinking and Alcohol Cue-Elicited Neural Activation: a Randomized Trial.” Translational Psychiatry, 2021.


BibTeX   Click to copy

@article{e2021a,
  title = {Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial},
  year = {2021},
  journal = {Translational Psychiatry},
  author = {Grodin, E. and Bujarski, S. and Towns, Brandon and Burnette, E. and Nieto, Steven J. and Lim, Aaron C and Lin, Johnny and Miotto, K. and Gillis, A. and Irwin, M. and Evans, C. and Ray, L.}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in